CORBION NV (CRBN.AS) Fundamental Analysis & Valuation

AMS:CRBN • NL0010583399

Current stock price

18.61 EUR
-0.58 (-3.02%)
Last:

This CRBN.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CRBN.AS Profitability Analysis

1.1 Basic Checks

  • In the past year CRBN was profitable.
  • In the past year CRBN had a positive cash flow from operations.
  • Each year in the past 5 years CRBN has been profitable.
  • Each year in the past 5 years CRBN had a positive operating cash flow.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.28%, CRBN is in the better half of the industry, outperforming 68.12% of the companies in the same industry.
  • CRBN has a better Return On Equity (10.07%) than 63.77% of its industry peers.
  • CRBN has a better Return On Invested Capital (8.67%) than 72.46% of its industry peers.
  • CRBN had an Average Return On Invested Capital over the past 3 years of 6.40%. This is in line with the industry average of 7.17%.
  • The 3 year average ROIC (6.40%) for CRBN is below the current ROIC(8.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.28%
ROE 10.07%
ROIC 8.67%
ROA(3y)7.34%
ROA(5y)6.63%
ROE(3y)15.47%
ROE(5y)14.99%
ROIC(3y)6.4%
ROIC(5y)6.39%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.90%, CRBN is in the better half of the industry, outperforming 60.87% of the companies in the same industry.
  • CRBN's Profit Margin has declined in the last couple of years.
  • CRBN has a Operating Margin of 9.97%. This is in the better half of the industry: CRBN outperforms 62.32% of its industry peers.
  • In the last couple of years the Operating Margin of CRBN has remained more or less at the same level.
  • CRBN has a Gross Margin of 26.41%. This is in the lower half of the industry: CRBN underperforms 60.87% of its industry peers.
  • CRBN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.97%
PM (TTM) 5.9%
GM 26.41%
OM growth 3Y10.27%
OM growth 5Y-0.1%
PM growth 3Y-1.49%
PM growth 5Y-4.45%
GM growth 3Y5.66%
GM growth 5Y-1.14%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5

2. CRBN.AS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRBN is still creating some value.
  • Compared to 1 year ago, CRBN has less shares outstanding
  • Compared to 5 years ago, CRBN has less shares outstanding
  • Compared to 1 year ago, CRBN has an improved debt to assets ratio.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • The Debt to FCF ratio of CRBN is 4.82, which is a neutral value as it means it would take CRBN, 4.82 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 4.82, CRBN is doing good in the industry, outperforming 68.12% of the companies in the same industry.
  • A Debt/Equity ratio of 0.47 indicates that CRBN is not too dependend on debt financing.
  • CRBN has a Debt to Equity ratio (0.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.82
Altman-Z N/A
ROIC/WACC1.43
WACC6.04%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.89 indicates that CRBN should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.89, CRBN perfoms like the industry average, outperforming 59.42% of the companies in the same industry.
  • A Quick Ratio of 1.11 indicates that CRBN should not have too much problems paying its short term obligations.
  • The Quick ratio of CRBN (1.11) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.11
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

3

3. CRBN.AS Growth Analysis

3.1 Past

  • CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.30%.
  • Measured over the past 5 years, CRBN shows a small growth in Earnings Per Share. The EPS has been growing by 0.98% on average per year.
  • Looking at the last year, CRBN shows a decrease in Revenue. The Revenue has decreased by -1.61% in the last year.
  • CRBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.14% yearly.
EPS 1Y (TTM)-60.3%
EPS 3Y-5.44%
EPS 5Y0.98%
EPS Q2Q%44.62%
Revenue 1Y (TTM)-1.61%
Revenue growth 3Y-4.56%
Revenue growth 5Y5.14%
Sales Q2Q%-4.49%

3.2 Future

  • CRBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.65% yearly.
  • CRBN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.19% yearly.
EPS Next Y11.51%
EPS Next 2Y11.86%
EPS Next 3Y9.65%
EPS Next 5YN/A
Revenue Next Year1.78%
Revenue Next 2Y2.74%
Revenue Next 3Y2.19%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

6

4. CRBN.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.43, which indicates a correct valuation of CRBN.
  • Compared to the rest of the industry, the Price/Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 75.36% of the companies listed in the same industry.
  • CRBN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.89.
  • The Price/Forward Earnings ratio is 12.09, which indicates a correct valuation of CRBN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 78.26% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. CRBN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.43
Fwd PE 12.09
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 73.91% of the companies listed in the same industry.
  • 86.96% of the companies in the same industry are more expensive than CRBN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.69
EV/EBITDA 7
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CRBN may justify a higher PE ratio.
PEG (NY)1.25
PEG (5Y)14.74
EPS Next 2Y11.86%
EPS Next 3Y9.65%

6

5. CRBN.AS Dividend Analysis

5.1 Amount

  • CRBN has a Yearly Dividend Yield of 3.34%. Purely for dividend investing, there may be better candidates out there.
  • CRBN's Dividend Yield is a higher than the industry average which is at 2.35.
  • CRBN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.34%

5.2 History

  • The dividend of CRBN has a limited annual growth rate of 2.76%.
Dividend Growth(5Y)2.76%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • 49.73% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
  • The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.73%
EPS Next 2Y11.86%
EPS Next 3Y9.65%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CRBN.AS Fundamentals: All Metrics, Ratios and Statistics

CORBION NV

AMS:CRBN (3/27/2026, 7:00:00 PM)

18.61

-0.58 (-3.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners91.96%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)1.27B
Net Income(TTM)74.80M
Analysts80
Price Target23.74 (27.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.34%
Yearly Dividend0.64
Dividend Growth(5Y)2.76%
DP49.73%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.59%
PT rev (3m)-0.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.54%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE 14.43
Fwd PE 12.09
P/S 0.86
P/FCF 11.69
P/OCF 6.74
P/B 1.46
P/tB 1.66
EV/EBITDA 7
EPS(TTM)1.29
EY6.93%
EPS(NY)1.54
Fwd EY8.27%
FCF(TTM)1.59
FCFY8.55%
OCF(TTM)2.76
OCFY14.84%
SpS21.76
BVpS12.75
TBVpS11.22
PEG (NY)1.25
PEG (5Y)14.74
Graham Number19.24
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.07%
ROCE 11.38%
ROIC 8.67%
ROICexc 9.03%
ROICexgc 9.85%
OM 9.97%
PM (TTM) 5.9%
GM 26.41%
FCFM 7.31%
ROA(3y)7.34%
ROA(5y)6.63%
ROE(3y)15.47%
ROE(5y)14.99%
ROIC(3y)6.4%
ROIC(5y)6.39%
ROICexc(3y)6.72%
ROICexc(5y)6.85%
ROICexgc(3y)7.49%
ROICexgc(5y)7.87%
ROCE(3y)8.41%
ROCE(5y)8.39%
ROICexgc growth 3Y-0.2%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.91%
ROICexc growth 5Y-2.42%
OM growth 3Y10.27%
OM growth 5Y-0.1%
PM growth 3Y-1.49%
PM growth 5Y-4.45%
GM growth 3Y5.66%
GM growth 5Y-1.14%
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.82
Debt/EBITDA 1.64
Cap/Depr 79.49%
Cap/Sales 5.38%
Interest Coverage 8.21
Cash Conversion 75.82%
Profit Quality 123.93%
Current Ratio 1.89
Quick Ratio 1.11
Altman-Z N/A
F-Score7
WACC6.04%
ROIC/WACC1.43
Cap/Depr(3y)117.66%
Cap/Depr(5y)178.72%
Cap/Sales(3y)7.91%
Cap/Sales(5y)10.76%
Profit Quality(3y)66%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.3%
EPS 3Y-5.44%
EPS 5Y0.98%
EPS Q2Q%44.62%
EPS Next Y11.51%
EPS Next 2Y11.86%
EPS Next 3Y9.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.61%
Revenue growth 3Y-4.56%
Revenue growth 5Y5.14%
Sales Q2Q%-4.49%
Revenue Next Year1.78%
Revenue Next 2Y2.74%
Revenue Next 3Y2.19%
Revenue Next 5YN/A
EBIT growth 1Y39.36%
EBIT growth 3Y5.24%
EBIT growth 5Y5.03%
EBIT Next Year80.79%
EBIT Next 3Y26.02%
EBIT Next 5YN/A
FCF growth 1Y-7.21%
FCF growth 3YN/A
FCF growth 5Y35.76%
OCF growth 1Y-12.6%
OCF growth 3Y60.39%
OCF growth 5Y8.1%

CORBION NV / CRBN.AS Fundamental Analysis FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


What is the valuation status of CORBION NV (CRBN.AS) stock?

ChartMill assigns a valuation rating of 6 / 10 to CORBION NV (CRBN.AS). This can be considered as Fairly Valued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CORBION NV?

The Earnings per Share (EPS) of CORBION NV (CRBN.AS) is expected to grow by 11.51% in the next year.


How sustainable is the dividend of CORBION NV (CRBN.AS) stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 49.73%.